Madrigal Pharmaceuticals (United States)

InstitutionResearch output, impact & collaborations

Madrigal Pharmaceuticals (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Madrigal Pharmaceuticals (United States)?

ScholarIQrecord summary

Madrigal Pharmaceuticals (United States) is a research organisation in West Conshohocken, United States. OpenAlex records 148 works and 7,281 citations for it. 1 researchers list it as their most recent affiliation.

How many works does Madrigal Pharmaceuticals (United States) have?

ScholarIQindexed works

Madrigal Pharmaceuticals (United States) has 148 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Madrigal Pharmaceuticals (United States) →

How many citations does Madrigal Pharmaceuticals (United States) have?

ScholarIQcitation count

Madrigal Pharmaceuticals (United States) has 7,281 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Madrigal Pharmaceuticals (United States) →

How many researchers are at Madrigal Pharmaceuticals (United States)?

ScholarIQresearcher count

Madrigal Pharmaceuticals (United States) has 1 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Madrigal Pharmaceuticals (United States)?

ScholarIQavg h-index

Madrigal Pharmaceuticals (United States) has an average h-index of 71 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Madrigal Pharmaceuticals (United States)?

ScholarIQror

The ROR for Madrigal Pharmaceuticals (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Madrigal Pharmaceuticals (United States)?

ScholarIQopenalex

The OpenAlex for Madrigal Pharmaceuticals (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Madrigal Pharmaceuticals (United States)?

ScholarIQtop researchers by citations

Rebecca Taub · Liver Disease Diagnosis and Treatment

214 works21,633 citations

What are the most-cited papers on Madrigal Pharmaceuticals (United States)?

ScholarIQmost cited works

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy, Jörn M. Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E. Moussa, Guy Neff, Mary E. Rinella, Quentin M. Anstee, Manal F. Abdelmalek, Zobair M. Younossi, Seth J. Baum, Sven Francque, Michael Charlton, Philip N. Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M. Pericàs, Rashmee Patil, Arun J. Sanyal, Mazen Noureddin, Meena B. Bansal, Naim Alkhouri, Laurent Castéra, Madhavi Rudraraju, Vlad Ratziu

New England Journal of Medicine. 20241,818 CitationsOPEN ACCESS

How much of the research on Madrigal Pharmaceuticals (United States) is open access?

ScholarIQopen access share

100%OPEN ACCESS

Gold

Green

100%

Hybrid

Bronze

Closed